Main information

  • Trade name:
  • FatBlaster Green Coffee Bean
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug



  • Available in:
  • FatBlaster Green Coffee Bean
  • Language:
  • English

Other information


  • Source:
  • Dept. of Health,Therapeutic Goods Administration - Australia
  • Authorization number:
  • 221461
  • Last update:
  • 08-10-2017

Public Assessment Report

Public Summary

Summary for ARTG Entry:


FatBlaster Green Coffee Bean

ARTG entry for

Medicine Listed


Cat Media Pty Ltd

Postal Address

PO Box 384,MONA VALE, NSW, 1660


ARTG Start Date


Product category




Approval area

Listed Medicines


Colouring agents used in listed medicine for ingestion, other than those listed for export only under section 25 of the Act, shall be only those included in

the list of 'Colourings permitted in medicines for oral use'.

The sponsor shall keep records relating to this listed medicine as are necessary to: (a) Expedite recall if necessary of any batch of the listed medicine,

(b) Identify the manufacturer(s) of each batch of the listed medicine. Where any part of or step in manufacture in Australia of the listed medicine is

sub-contracted to a third party who is not the sponsor, copies of relevant Good Manufacturing Practice agreements relation to such manufacture shall be


The sponsor shall retain records of the distribution of the listed medicine for a period of five years and shall provide the records or copies of the records

to the Complementary Medicines Branch, Therapeutic Goods Administration, upon request.

The sponsor of the listed medicine must not, by any means, intentionally or recklessly advertise the medicine for an indication other than those accepted

in relation to the inclusion of the medicine in the Register.

All reports of adverse reactions or similar experiences associated with the use or administration of the listed medicine shall be notified to the Head, Office

of Product Review, Therapeutic Goods Administration, as soon as practicable after the sponsor of the goods becomes aware of those reports. Sponsors

of listed medicines must retain records of such reports for a period of not less than 18 months from the day the Head, Office of Product Review is notified

of the report or reports.

The sponsor shall not supply the listed medicine after the expiry date of the goods.

Where a listed medicine is distributed overseas as well as in Australia, product recall or any other regulatory action taken in relation to the medicine

outside Australia which has or may have relevance to the quality, safety or efficacy of the goods distributed in Australia, must be notified to the National

Manager Therapeutic Goods Administration, immediately the action or information is known to the sponsor.


1. FatBlaster Green Coffee Bean

Product Type

Single Medicine Product

Effective date



No Warnings included on Record

Standard Indications

Specific Indications

Help to : - Limit sugar absorption to help fat oxidation. ± Help maintain healthy sugar metabolism# . #PLUS, CGA can also help to maintain healthy blood

sugar levels after a meal in healthy individuals.

The body's natural function is to burn sugar and carbohydrates from your diet as its primary source of energy. If that energy source is exhausted, the

body then looks for stored body fat to burn as an alternative energy source. Known to enhance fat oxidation & reduce fat storage*.

*Chlorogenic acid CGA is thought to limit/reduce the release of sugar into the bloodstream, helping to minimise/therefore minimising the amount that is

available for the body to use as energy. It is thought that as the body needs more energy than what is available in the bloodstream, it then looks to/

burning /oxidising/stored body fat as energy. A healthy calorie controlled diet combined with exercise may help you burn more calories and support

healthy weight maintenance. Take in conjunction with a healthy calorie-controlled diet & exercise program.

Additional Product information

Pack Size/Poison information

Pack Size

Poison Schedule


1. Formulation 1

Dosage Form

Tablet, film coated

Route of Administration


Visual Identification

Active Ingredients

Coffea canephora

380 mg

Equivalent: Coffea canephora (Dry)

7.6 g

Public Summary

Page 1 of

Produced at 26.11.2017 at 12:54:34 AEDT

This is not an ARTG Certificate document.

The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.

Visit www.tga.gov.au for contact information

© Commonwealth of Australia.This work is copyright.You are not permitted to re-transmit, distribute or commercialise the material without obtaining prior

written approval from the Commonwealth.Further details can be found at http://www.tga.gov.au/about/website-copyright.htm.

Public Summary

Page 2 of

Produced at 26.11.2017 at 12:54:34 AEDT

This is not an ARTG Certificate document.

The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.

Visit www.tga.gov.au for contact information